Four seasonal human coronaviruses were circulating widely prior to the COVID-19 pandemic, accounting for ~1030% of upper respiratory tract infections [10]
Information presented throughout the platform references compounds frequently discussed in scientific literature, including peptides, longevity-related molecules, and other research compounds studied in laboratory settings
Furthermore, the procedure may be done under general anesthesia, regional anesthesia, or local anesthesia
Researchers designing combination protocols can order separate batches with separate batch-specific COAs, which is generally required for research protocol documentation regardless of whether the compounds are used sequentially or in parallel
Its activity can be reduced in physiological conditions, it is susceptible to proteolytic degradation, and it can exhibit cytotoxicity at high concentrations